Galderma Associates Itself to Cartier’s Women’s Initiative Awards to Recognize Female Entrepreneurs From Around the Globe
PARIS, Oct. 16 /PRNewswire/ — Galderma Pharma SA is proud to announce that President and CEO Humberto C. Antunes has served as Cartier Women’s Initiative Awards Jury President for North America. Jury members for the prestigious business plan competition are chosen because of their achievements in the business, non-profit and academic fields, as well as their interest in women’s issues.
The awards, an annual distinction supporting innovative woman-led business projects, were created by Cartier and the Women’s Forum for the Economy and Society. The program honors five innovative business projects from women, one per continent, and awards each with a $20,000 (US) grant and coaching support for one year. The 2007 Award ceremony was held on October 11, 2007, at the Women’s Forum in Deauville, France.
“I want to express my deepest admiration for Cartier’s initiative and the special support of Cartier’s CEO for North America, Frederic de Narp. I am honored to have been chosen to lead the North American panel of jurists,” said Antunes. Galderma is one of the world’s largest dermatology pharmaceutical companies, has a presence in 65 countries, has one of the largest research facilities dedicated to dermatology and provides innovative therapeutic skincare solutions to meet the needs of dermatology patients and physicians. Antunes is an active member in many foundations and associations such as the Women’s Dermatologic Society and the American Skin Association.
“Start-up initiatives by women are vital and pave the way for future generations of women by passing on examples of courage, passion and perseverance,” said Antunes.
“Although the number of female entrepreneurs has increased in recent years, women in business still face specific obstacles.” Antunes said. “This program is valuable because it addresses those obstacles by offering the financial backing, quality coaching services and networking that can help women succeed.”
“Jury members evaluated several exciting business plans and concepts based on creativity, sustainability and social impact. The choice was very difficult among so many outstanding business plans,” said Antunes.
The five promising entrepreneurs recognized are: Laureate for Africa: Lucie Avoaka, project Santa Maria Medical Center (Cote d’Ivoire), healthcare provider in the underprivileged region of Abobo Laureate for Asia: Nandini Pandhi and Yasmina McCarty, project GreenMango (India), a mobile phone and internet-based virtual marketplace for low-income entrepreneurs and their customers in developing countries Laureate for Europe: Bettina Gotzenberger, project LOmasLEGAL (Spain), low-cost legal services available from high-street stores, over the phone, and via internet Laureate for Latin America: Antonia Sanin, project The Globe (Colombia), day-care center for children aged 3 to 6 which offers educational products and services developed from the experiences learned at the centre (workshops, manuals, blog…) Laureate for North America: Angel Chang, project Angel Chang LLC (USA), luxury apparel with “performance” elements and functional designs: special stain-proof, wrinkle-free and odor-free material, color-changing silkscreen prints, 3-D optical illusion prints, fiber optics etc. About Galderma
Created in 1981 as a joint venture between Nestle and L’Oreal, Galderma is one of the leading dermatology companies in the world according to recent IMS D-Class survey. With a worldwide presence in 65 countries, Galderma has over 900 sales representatives dedicated to dermatology. Galderma is a fully integrated specialty pharmaceutical company with a global sales and marketing structure and worldwide product development capability. Galderma provides innovative therapeutic skincare solutions to meet the needs of dermatology patients and physicians. The company is committed to improving the health of skin with an extensive line of products that treat a range of conditions including: acne, rosacea, fungal nail infections, psoriasis/SRD (steroid-responsive dermatoses), pigmentary disorders, skin cancers and medical products for skin senescence.
With a new research and development center in Sophia Antipolis (France), Galderma has one of the largest R&D facilities dedicated to dermatology. Galderma is also poised to continue making significant impact on dermatology treatments with the introduction of exciting technology and products on the horizon.
Galderma Laboratories
CONTACT: Dale Weiss of Galderma Laboratories, +1-817-961-5186,dale.weiss@galderma.com